Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Recognized by America's Top Doctors for 2017
Recognized in Philadelphia magazine's annual Top Docs issues for 2018 and 2019
Radiation Oncology, 2007
Widener Ground Level
800 Spruce Street
Philadelphia, PA 19107
A facility of Pennsylvania Hospital
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
W. Tristram Arscott, MD; Kathleen Gray, RN; Dennis Kuska, RN; Suneel Nagda, MD; Robert Lustig, MD; Michelle Alonso-Basanta, MD PhD; James M. Metz, MD; Joshua Jones, MD, MA: Evaluating the impact of secure mobile messaging on communication and cancer care team satisfaction in a large radiation oncology clinic Journal of Oncology Practice : 2019.
Ruangkanchanasetr R, Lee JYK, NAGDA SN, Geiger GA, Kolker JD, Bigelow DC, Ruckenstein MJ, Nasrallah M5, Alonso-Basanta M.: Toxicity of Gamma Knife Radiosurgery May Be Greater in Patients with Lower Cranial Nerve Schwannomas. J Neurol Surg B Skull Base 79 (6): 2018.
Gui Hongxing, Lhospital Elliott, Staddon Arthur P, NAGDA SN, Zager Eric L, Zhang Paul J L, Brooks John S: Combined Sclerosing and Spindle Cell Rhabdomyosarcoma in Previous Craniotomy Site: A Case Report and a Review of the Literature. International journal of surgical pathology : 1066896918802030,2018.
Guttmann DM, Gabriel P, Kennedy C, Rate W, Grizos W, NAGDA SN, Wojtowicz L, Lin L, Freedman GM: Comparison of acute toxicities between contemporary forward-planned 3D conformal radiotherapy and inverse-planned intensity-modulated radiotherapy for whole breast radiation Breast J : 2018.
Alite F, Stang K, Balasubramanian N, Adams W, Shaikh M, Small C, Sethi A, NAGDA SN, Emami B, Harkenrider M: Local control dependence on consecutive vs. nonconsecutive fractionation in lung stereotactic body radiation therapy. Radiother Oncol 121 (1): 9-14,2016.
Baumann BC, NAGDA SN, Kolker JD, Levin WP, Weber KL, Berman AT, Staddon A, Hartner L, Hahn SM, Glatstein E, Simone CB: Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection. J Surg Oncol 114 (1): 65-9,2016.
Chowdhury IH, Ojerholm E, McMillan MT, Miller De, Kolker JD, Kurtz G, Dorsey JF, NAGDA SN, Geiger GA, Brem S, O'Rourke DM, Zager EL, Gangadhar T, Schuchter L, Lee JY, Alonso-Basanta M: Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases. Radiat Oncol 10 : 248,2015.
Vogel J, Ojerholm E, Hollander A, Briola C, Mooij R, Bieda M, Kolker J, NAGDA SN, Geiger G, Dorsey J, Lustig R, O'Rourke DM, Brem S, Lee J, Alonso-Basanta M: Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases. Radiat Oncol 10 : 221,2015.
F. Alite, K. Stang, M.P. Shaikh, C. Small, A. Sethi, S. Nagda, B. Emami, M.M. Harkenrider: Local Control Dependence on Consecutive Versus Nonconsecutive Fractionation in Lung SBRT: A Propensity Score Matched Analysis ASTRO Annual Meeting : 2015.
Guttman D, Gabriel P, Lin L, Kennedy C, Rate W, Grizos W, Nagda SN, Wojtowicz L, Freedman G: Contemporary Forward Planned 3-D Conformal Radiation Therapy: A Wise Choice for Whole Breast Radiation ASTRO Annual Meeting : 2015.
Pennsylvania HospitalWidener Basement Level800 Spruce Street
Phone: (215) 829-3873
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.